{
    "Trade/Device Name(s)": [
        "IWL2020 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Roche Diabetes Care, Inc.",
    "510(k) Number": "K203711",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160944"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "January 31, 2022",
    "Summary Letter Received Date": "February 1, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood (fingertip)"
    ],
    "Specimen Container(s)": [
        "Black flip top round vial (test strip container)"
    ],
    "Instrument(s)/Platform(s)": [
        "IWL2020 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection"
    ],
    "Methodologies": [
        "Enzymatic assay (FAD-GDH)",
        "Amperometric measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Roche IWL2020 Blood Glucose Monitoring System utilizing FAD-GDH amperometric measurement for self-monitoring of blood glucose at home",
    "Indications for Use Summary": "Quantitatively measures glucose in fresh capillary whole blood from the fingertip as an aid in monitoring effectiveness of glucose control for single patient home use; not for diagnosis, diabetes screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}